Targeted peptide inserts in AAV capsids improve CNS and muscle transduction while helping evade pre-existing neutralizing antibodies.
Synthetic liver-specific enhancer elements boost hepatic gene expression in compact vectors while minimizing off-target expression.
Four rtTA mutations improve tetracycline sensitivity and suppress Tet-On leakiness, enabling tighter and less toxic transgene expression.
A succinate-pathway balanced lethal strategy keeps expression plasmids in daughter cells without antibiotics, lowering fermentation cost.
Modified promoter nucleotides boost HisE and HisG expression in Corynebacterium, raising glycine output while preserving glutamic acid productivity.
Constitutive ERN circuits classify cells from miRNA profiles while reducing toxicity and enabling rapid multi-output gene expression.
A CG-rich β-actin fragment placed upstream of CMV helps prevent promoter silencing and boosts recombinant antibody yield in CHO cells.
A UCP1 enhancer-promoter drives VGLL4 expression in brown fat and liver cells to increase BAT, reduce WAT, and improve metabolic health.
Modified rAAV capsids and a truncated calcitonin promoter improve MTC cell transduction and targeted therapeutic gene expression.
A compact SRF-UCOE keeps chromatin open to resist silencing, methylation, and position effects for durable transgene expression.
Engineered gp120-binding sites target conserved HIV-1 epitopes to improve neutralization breadth, potency, and resistance to viral escape.
Specific AAV capsid amino acid changes improve CNS and liver tropism while helping vectors evade pre-existing antibody neutralization.
Viral replicase and optimized UTR design boost self-replicating RNA expression while lowering immunogenicity and dose needs.
Direct renal artery catheter infusion improves viral vector delivery to glomeruli and podocytes while limiting systemic spread.
A dual-vector MAI-seq layout separates insulators from silencers, enabling accurate genome-wide screening across species.
Enhancer-blocking insulators and modified globin control regions enable erythroid-specific expression while lowering insertional oncogenesis risk.
A LuxI/LuxR promoter system auto-induces target gene expression in engineered E. coli, balancing growth and production without toxic inducers.
Hypoxia- and inflammation-responsive adenoviral replication improves tumor selectivity while CD40L and 4-1BBL boost antitumor immunity.
Inducible VA RNA transcription helps rAAV packaging cell lines avoid toxic rep/helper expression while improving production uniformity.
AAV delivery of tandem circRNA constructs with intronic elements and IRES boosts multi-circRNA expression across heart, liver, and muscle.
Engineered M13 phages bind Spike S1 to capture and concentrate SARS-CoV-2 from samples, enabling sensitive detection at low viral loads.
Group I self-splicing introns and stable end structures circularize RNA to resist exonuclease decay and extend protein expression.
Targeted inhibition of salt-response nucleotide sequences improves plant or algae survival and growth under high salinity.
Targeted nucleotide changes at codons 3, 4, and 5 tune protein abundance without changing amino acid sequence or using complex expression methods.
Catheter infusion through the renal artery bypasses glomerular permselectivity to improve podocyte gene delivery with kidney-localized expression.